1.25

3.85% -0.05

After Hours: 1.20 -0.05 -4.00%

Lunai Bioworks Inc (LNAI)

Overview News Price History Discussions Forecast

Lunai Bioworks Inc stock is traded at $1.25, with a volume of 206.49K. It is down -3.85% in the last 24 hours and up +6.84% over the past month. Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Previous Close:

$1.30

Open:

$1.28

24h Volume:

206.49K

Relative Volume:

0.06

Market Cap:

$29.29M

Revenue:

Net Income/Loss:

$-178.01M

P/E Ratio:

-0.1501

EPS:

-8.326

Net Cash Flow:

$-7.87M

1W Performance:

+5.93%

1M Performance:

+6.84%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$1.20

$1.2899

1-Week Range:

$1.1101

$1.33

52-Week Range:

$0.81

$1.66

Lunai Bioworks Inc Stock (LNAI) Company Profile

Name

Lunai Bioworks Inc

Sector

Healthcare (1133)

Industry

Biotechnology (634)

Phone

45 39179840

Address

CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES

Employee

Twitter

Next Earnings Date

Latest SEC Filings

LNAI's Discussions on Twitter

Compare LNAI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNAI Lunai Bioworks Inc	1.25	30.46M	0	-178.01M	-7.87M	-8.326
VRTX Vertex Pharmaceuticals Inc	455.48	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	718.36	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.12	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	901.17	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.00	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Lunai Bioworks Inc Stock (LNAI) Latest News

Dec 04, 2025

Lunai Bioworks (LNAI) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025

Dec 03, 2025

Lunai Bioworks enters sales agreement with Dawson James SecuritiesSEC filing - marketscreener.com

Dec 03, 2025

Lunai Bioworks Enters Sales Agreement with Dawson James - TipRanks

Dec 03, 2025

Dec 01, 2025

Does Lunai Bioworks Inc (LNAI) offer a good opportunity for investors? - Setenews

Dec 01, 2025

Nov 29, 2025

Lunai Bioworks’ immune cell therapy shows tumor regression, wins first license - MSN

Nov 29, 2025

Nov 28, 2025

Lunai Bioworks stock soars after securing first licensing deal for cancer therapy - MSN

Nov 28, 2025

Lunai Bioworks - The Pharma Letter

Nov 28, 2025

Nov 27, 2025

Lunai Bioworks lands first licensing deal for off-the-shelf cancer immunotherapy - The Pharma Letter

Nov 27, 2025

Nov 26, 2025

There is no way Lunai Bioworks Inc (LNAI) can keep these numbers up - Setenews

Nov 26, 2025

Nov 25, 2025

Lunai Bioworks Inc (2Q50.MU) latest stock news and headlines - Yahoo Finance Australia

Nov 25, 2025